A Pilot Clinical Trial to Evaluate the Biological Activity of HDAC (Histone Deacetylase Transferases) Inhibition on ER and PR Expression in Triple Negative Invasive Breast Cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Vorinostat (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 09 Oct 2012 New trial record